Carnitine and hemodialysis

American Journal of Kidney Diseases

Volumn 41, Issue 3 SUPPL. 1, 2003, Pages

  Bellinghieri, Guido ^b   Santoro, Domenico ^a   Calvani, Menotti ^b   Mallamace, Agostino ^b   Savica, Vincenzo ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE

Author keywords

Acyl to free carnitine ratio; Anemia; Carnitine; Dialysis; Metabolism

Indexed keywords

ANTIOXIDANT; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; ERYTHROPOIETIN; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANEMIA; ASTHENIA; CARDIOMYOPATHY; CARNITINE DEFICIENCY; CONFERENCE PAPER; DIET SUPPLEMENTATION; DOSE RESPONSE; ENZYME ACTIVITY; ERYTHROCYTE; EUKARYOTIC CELL; FATTY ACID OXIDATION; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL ASSESSMENT; HEART DISEASE; HEMODIALYSIS; HUMAN; HYPOTENSION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MUSCLE CRAMP; MUSCLE DISEASE; MUSCLE WEAKNESS; PROKARYOSIS; PROTEIN INTAKE; PROTEIN METABOLISM; PROTEIN SYNTHESIS; UREMIA;

EID: 0037374348     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50099     Document Type: Conference Paper

References (32)

1. Gulewitsch W, Krimberg R: Zur Kenntnis der Extraktivstoffe der Muskeln. Z. Physiol Chem 45:326-330, 1905
2. Wolfgang R: Carnitine: Historical overview, in Seim H, Loster H (eds): Carnitine Pathobiochemical Basis and Clinical Applications. Bochum, Germany, Ponte Press Verlags-GmbH, 1996, pp 3-7 (chap 1)
3. Karpati G, Carpenter S, Engel AG, et al: The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology 25:16-24, 1975
4. Zammit VA: Carnitine acyltransferase: Functional significance of subcellular distribution and membrane topology. Progress Lipid Res 38:199-224, 1999
5. Bremer J: The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 28:297-301, 1990
6. Sidossis LS, Sturt CA, Shulman GI, Lopaschuck GD, Wolfe RR: Glucose plus insulin regulate fax oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest 98:2244-2250, 1996
7. Peluso G, Nicolai E, Reda E, Benatti P, Barbarisi A, Calvani M: Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 182:339-350, 2000
8. Bremer J: The role of Carnitine in cell metabolism, in de Simone C and Famularo G (eds): Carnitine Today. Heidelberg, Germany, Springer-Verlag, 1997, pp 1-37
9. Ferrari R, Di Mauro S, Shervood G: L-Carnitine and its Role in Medicine: From Function to Therapy. London, England, Academic Press, 1992
10. Rubio JC, de Bustos F, Molina JA, et al: Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease. J Neurol Sci 155:192-195, 1998
11. McGarry JD, Mannaerts GP, Foster DW: A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and keratogenesis. J Clin Invest 60:265-270, 1977
12. Evans AM, Faull R, Fornasini G, et al: Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term haemodialysis. Clin Pharmacol Ther 68:238-249, 2000
13. Shaw RD, Li BUK, Hamilton JW, Shug AL, Olsen WA: Carnitine transport in rat small intestine. Am J Physiol 245:G376-G381, 1983
14. Wanner C, Förster-Wanner S, Rössle C, Furst P, Schollmeyer P, Horl WH: Carnitine metabolism in patients with chronic renal failure: Effect of L-carnitine supplementation. Kidney Int Suppl 22:132S: 135S, 1987
15. Ohashi R, Tamai I, Yabuuchi H, et al: Na(+)dependent carnitine transport by organic cation transporter (OCTN2): Its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291:778-784, 1999
16. Zhu Y, Jong MC, Frazer KA, et al: Genomic interval engineering of mice identifies a novel modulator of triglycerides production. Proc Natl Acad Sci U S A 97:1137-1142, 2000
17. Lennon DL, Shrago E, Madden M, Nagle F, Hanson P, Zimmerman S: Carnitine status, plasma lipid profiles, and exercise capacity of dialysis patients: Effects of a submaximal exercise program. Metabolism 35:728-735, 1986
18. De los Reyes B, Navarro JA, Perez-Garcia R, et al: Effects of L-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophospholipid acyltransferase in uremia. Am J Clin Nutr 67:386-390, 1998
19. Spagnoli LG, Palmieri G, Mauriello A, et al: Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle. Nephron 55:16-23, 1990
20. Guarnieri G, Situlin R, Biolo G: Carnitine metabolism in uremia. Am J Kidney Dis 38:S63-67, 2001 (suppl 4)
21. Bellinghieri G, Savica V, Mallamace A, et al: Correlation between increased serum and tissue L-Carnitine levels and improved muscle symptoms in hemodialysis patients. Am J Clin Nutr 38:523-531, 1983
22. Brass EP, Adler S, Sietsema KE, Hiatt WR, Orlando AM, Amato A: Intravenous L-Carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis. Am J Kidney Dis 37:1018-1028, 2001
23. Debska-Slizien, Kawecka A, Wojanarowsky K, et al: Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients. Int J Artif Organs 23:90-96, 2000.
24. Matsumoto Y, Sato M, Ohashi H, et al: Effects of L-carnitine supplementation on cardiac morbidity in haemodialysis patients. Am J Nephrol 20:201-207, 2001
25. Matsumoto Y, Amano I, Hirose S, et al: Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin. Blood Purif 19:24-32, 2001
26. Labonia WD, Morelli OH Jr, Gimenez MI, Freuler PV, Morelli OH: Effects of levo-carnitine on sodium transport in erythrocytes from dialysed uremic patients. Kidney Int 32:754-759, 1987
27. Matsumura M, Hatakeyama S, Koni I, Mabuchi H, Muramoto H: Correlation between serum carnitine levels and erythrocyte osmotic fragility in haemodialysis patients. Nephron 72:574-578, 1996
28. Nikolaos S, George A, Telemachos T, Maria S, Yannis M, Konstantinos M: Effect of L-carnitine supplementation red blood cells deformability in hemodialysis patients. Ren Fail 22:73-80, 2000
29. Wanic-Kossowska M, Piszczek I, Rogacka D, Czarnecki R, Koziol L, Czekalki S: The efficacy of the substitution of carnivit in patients with chronic failure treated with hemodialysis. Pol Arch Med Wewn 102:885-891, 1999
30. Sakurabayashi T, Takaesu Y, Haginoshita S, et al: Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients. Am J Nephrol 19:480-484, 1999
31. Hurot JM, Cucherat M, Haugh M, Fouque D: Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 13:708-714, 2002
32. FDA approves Carnitor for dialysis. SCRIP World Pharmaceutical News 05-06-2000